Quetiapine Tablet, Extended Release
Product Images NDC 63629-5944

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 63629-5944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636295944)

Label (Lbl636295944)
This text consists of information on a medication containing Quetiapine Fumarate in tablet form, with a dosage of 400 mg. It also includes details on the storage conditions, dosage instructions, and a warning to keep the medication out of reach of children. The tablet should be swallowed whole and not split, crushed, or chewed. The package insert QR code can provide additional prescribing information. The medication is manufactured by Macleods Pharmaceuticals and repackaged by Bryant Ranch Prepack, Inc.*
FDA Label Image

Quetiapine-fig-1 (Quetiapine Fig 1)

FDA Label Image

Quetiapine-fig-2 (Quetiapine Fig 2)

FDA Label Image

Quetiapine-fig-3 (Quetiapine Fig 3)

FDA Label Image

Quetiapine-fig-4 (Quetiapine Fig 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.